Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA2J0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,989
Award facts
- Contract value 100% obligated
- $55,989.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $55,989.24 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order represents non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider. The company serves as a critical federal vendor for medical procurement, particularly for military and veteran healthcare systems, supplying medications across multiple therapeutic domains including specialty treatments, vaccines, and medical devices. This delivery order for Biktarvy, an antiretroviral medication used in HIV treatment regimens, exemplifies the company's role in fulfilling essential pharmaceutical needs for the Defense Health Agency and other government healthcare systems through competitively awarded federal contracts.
Quick answers
Who was awarded contract SPE2DR26FA2J0?
SPE2DR26FA2J0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FA2J0 worth?
The government has obligated $55,989 on SPE2DR26FA2J0.
Is contract SPE2DR26FA2J0 an order under another contract?
Yes. SPE2DR26FA2J0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2J0 competed?
The extent of competition for SPE2DR26FA2J0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award